日本語 
Pharma
Aisin Corporation and JEOL Ltd. have jointly developed a portable bulk compact NMR system that brings nuclear magnetic resonance analysis closer to where research actually happens. This setup does not…
Chugai and Gero Join Forces on Aging Disease Therapies
Chugai Pharmaceutical Co., Ltd. and Singapore-based biotechnology firm Gero PTE. LTD. Gero…
Elix and LINC Unveil AI Drug Platform Using Pharma Data
Elix Inc. and the Life Intelligence Consortium (LINC), a general incorporated association…
Actair® Promotion in Japan Transitions to CEOLIA Pharma
Stallergenes Greer, together with Shionogi & Co., Ltd. and CEOLIA Pharma Co.,…
Alpha Fusion, Curadh MTR Partner on Astatine-211 Drugs
Alpha Fusion, Inc. and Curadh MTR, Inc. They plan to create a…
PHC secures exclusive rights to MaxCyte ExPERT in Japan
The Biomedical Division of PHC Corporation, a subsidiary of PHC Holdings Corporation…
PRD Therapeutics Begins First Human Trial for PRD001
PRD Therapeutics Inc. has announced a first-in-human clinical trial for PRD001. This is…
Axcelead, A2 Healthcare Unite for Pharma R\&D in Japan
Axcelead, Inc., A2 Healthcare Corporation and another company have formed a partnership.…
Fujirebio Acquires PSG to Boost Biological Material Supply
H.U. Group Holdings Inc., through its wholly owned subsidiary Fujirebio Holdings, Inc.…
Chugai and Gero Join Forces on Aging Disease Therapies
Chugai Pharmaceutical Co., Ltd. and Singapore-based biotechnology firm Gero PTE. LTD. Gero…
Elix and LINC Unveil AI Drug Platform Using Pharma Data
Elix Inc. and the Life Intelligence Consortium (LINC), a general incorporated association…
Actair® Promotion in Japan Transitions to CEOLIA Pharma
Stallergenes Greer, together with Shionogi & Co., Ltd. and CEOLIA Pharma Co.,…
Alpha Fusion, Curadh MTR Partner on Astatine-211 Drugs
Alpha Fusion, Inc. and Curadh MTR, Inc. They plan to create a…
PHC secures exclusive rights to MaxCyte ExPERT in Japan
The Biomedical Division of PHC Corporation, a subsidiary of PHC Holdings Corporation…
PRD Therapeutics Begins First Human Trial for PRD001
PRD Therapeutics Inc. has announced a first-in-human clinical trial for PRD001. This is…
Axcelead, A2 Healthcare Unite for Pharma R\&D in Japan
Axcelead, Inc., A2 Healthcare Corporation and another company have formed a partnership.…
Fujirebio Acquires PSG to Boost Biological Material Supply
H.U. Group Holdings Inc., through its wholly owned subsidiary Fujirebio Holdings, Inc.…
English